Investing

Published September 11, 2026

NRx Pharmaceuticals at Cantor conference: ketamine push gains momentum

Read the full story at Investing

NRx is also pursuing a real-world-evidence path for a ketamine label tied to depression and suicidality. HOPE Therapeutics is expanding clinic.